This study suggested that zeaxanthin has the potential to inhibit the development of diabetic retinopathy via ameliorating oxidative stress and inhibition of VEGF expression and inflammation, which raises the possibility that it could be used as an adjunct therapy to help prevent vision loss in patients with diabetes. The gene discussed is VEGFA; the disease is diabetes mellitus.